摘要 |
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of formula (I) or pharmaceutically acceptable salts thereof, wherein Y<SUB>1</SUB>, R<SUP>17</SUP>, R<SUP>2</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP>, X<SUP>2</SUP> and n are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. |
申请人 |
PFIZER PRODUCTS INC.;BERKE, HELEN;DUPLANTIER, ALLEN, JACOB;EFREMOV, IVAN;MCHARDY, STANTON, FURST;ROGERS, BRUCE, NELSEN;QIAN, WEIMIN;ZHANG, LEI;ZHANG, QIAN |
发明人 |
BERKE, HELEN;DUPLANTIER, ALLEN, JACOB;EFREMOV, IVAN;MCHARDY, STANTON, FURST;ROGERS, BRUCE, NELSEN;QIAN, WEIMIN;ZHANG, LEI;ZHANG, QIAN |